Company Filing History:
Years Active: 2016
Title: Mi Young Hahn: Innovator in Tuberculosis Treatment
Introduction
Mi Young Hahn is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for tuberculosis. Her innovative approach combines scientific research with practical applications, aiming to improve health outcomes for patients.
Latest Patents
Mi Young Hahn holds a patent for a pharmaceutical composition designed for preventing or treating tuberculosis. This composition includes a pharmaceutically effective amount of a compound that inhibits the expression and activity of CO-DH in tubercles. The invention effectively blocks the detoxification of carbon monoxide, which is crucial for the survival of the tuberculosis bacteria. Importantly, the compound is safe for human use, as it targets CO-DH, which is not present in the human body. Additionally, this compound demonstrates a synergistic effect when used alongside conventional tuberculostatic drugs, enhancing its efficacy in treating tuberculosis. She has 1 patent to her name.
Career Highlights
Mi Young Hahn is affiliated with Yonsei University, where she conducts her research and develops her innovative pharmaceutical compositions. Her work is characterized by a commitment to addressing critical health challenges, particularly in infectious diseases.
Collaborations
Mi Young Hahn collaborates with esteemed colleagues, including Young Min Kim and Seung Jung Han. These partnerships enhance her research efforts and contribute to the advancement of tuberculosis treatment.
Conclusion
Mi Young Hahn's contributions to the field of pharmaceuticals, particularly in tuberculosis treatment, highlight her innovative spirit and dedication to improving public health. Her work exemplifies the impact of scientific research on real-world health challenges.